Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Journal of Reports in Pharmaceutical Sciences
  4. Articles

  5. Effect of Ethyl Acetate and Aqueous Fractions of Ziziphus jujuba Extract on Biochemical and Hematological Parameters in Rat
  6. Scopus by Title (Ref)

Journal of Reports in Pharmaceutical Sciences

Home
Current IssueAll IssuesIn PressAccepted ManuscriptsSearch
Instructions
Journal InformationEditors & BoardsIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Publication Malpractice StatementReviewer and AE Registration FormSupportContact Us
APCAnnouncement of New Publisher
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Ziziphus jujuba (Jujube) in Metabolic Syndrome: From Traditional Medicine to Scientific Validation

- Ghasemzadeh Rahbardar M. , et al.

2. Jujube (Ziziphus jujuba Mill. (Rhamnaceae)): a review on its pharmacological properties and phytochemistry

- Aafi E. , et al.

3. New bioactive constituents characterized by LC–MS/MS in optimized microwave extract of jujube seeds (Zizyphus lotus L.)

- Berkani F. , et al.

4. Ultrasound assisted extraction of phenolic compounds from a jujube by-product with valuable bioactivities

- Berkani F. , et al.

HomeInstructionsAPCAnnouncement of New Publisher

Articles

  • Current Issue
  • All Issues
  • In Press
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Editors & Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Publication Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.